CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-07 | Smith Michael Alexander Chief Legal Officer | Sale | −709 | $175.07 | $124K | 58,090 |
| 2026-01-07 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,434 | $175.84 | $252K | 91,705 |
| 2026-01-07 | Adsett Roger Chief Operating Officer | Sale | −802 | $175.07 | $140K | 109,660 |
| 2026-01-07 | Bonstein Sara Chief Financial Officer | Sale | −1,678 | $175.07 | $294K | 81,953 |
| 2026-01-07 | Lewis William Chair and CEO | Sale | −2,357 | $175.07 | $413K | 318,630 |
| 2026-01-06 | Smith Michael Alexander Chief Legal Officer | Sale | −1,396 | $173.33 | $242K | 58,799 |
| 2026-01-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +8,570 | $26.43 | $227K | 103,324 |
| 2026-01-06 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −4,783 | $173.47 | $830K | 98,541 |
| 2026-01-06 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −2,830 | $174.21 | $493K | 95,711 |
| 2026-01-06 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −957 | $175.01 | $167K | 94,754 |
| 2026-01-06 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,615 | $173.33 | $280K | 93,139 |
| 2026-01-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −8,570 | 0 | ||
| 2026-01-06 | Adsett Roger Chief Operating Officer | Sale | −1,429 | $173.33 | $248K | 110,462 |
| 2026-01-06 | Bonstein Sara Chief Financial Officer | Sale | −1,517 | $173.33 | $263K | 83,631 |
| 2026-01-06 | Lewis William Chair and CEO | Sale | −4,096 | $173.33 | $710K | 320,987 |
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +4,358 | $19.74 | $86K | 99,112 |
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +7,945 | $29.13 | $231K | 107,057 |
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −2,799 | $169.29 | $474K | 104,258 |
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −3,205 | $170.61 | $547K | 101,053 |
| 2026-01-05 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −2,836 | $171.19 | $485K | 98,217 |
Page 11 of 23 · 448 trades